DK144944C - Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf - Google Patents

Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf

Info

Publication number
DK144944C
DK144944C DK76578A DK76578A DK144944C DK 144944 C DK144944 C DK 144944C DK 76578 A DK76578 A DK 76578A DK 76578 A DK76578 A DK 76578A DK 144944 C DK144944 C DK 144944C
Authority
DK
Denmark
Prior art keywords
hydropholic
methyltetra
salts
preparing
acid
Prior art date
Application number
DK76578A
Other languages
Danish (da)
English (en)
Other versions
DK76578A (da
DK144944B (da
Inventor
F Gennari
Original Assignee
Bioresearch Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch Sas filed Critical Bioresearch Sas
Publication of DK76578A publication Critical patent/DK76578A/da
Publication of DK144944B publication Critical patent/DK144944B/da
Application granted granted Critical
Publication of DK144944C publication Critical patent/DK144944C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK76578A 1977-02-22 1978-02-21 Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf DK144944C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB729077 1977-02-22
GB7290/77A GB1572137A (en) 1977-02-22 1977-02-22 Stable compositions for therapeutic use based on d,1-5-methyltetrahydrofolic acid and its salts

Publications (3)

Publication Number Publication Date
DK76578A DK76578A (da) 1978-08-23
DK144944B DK144944B (da) 1982-07-12
DK144944C true DK144944C (da) 1982-11-29

Family

ID=9830275

Family Applications (1)

Application Number Title Priority Date Filing Date
DK76578A DK144944C (da) 1977-02-22 1978-02-21 Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf

Country Status (32)

Country Link
JP (1) JPS5831353B2 (xx)
AR (1) AR215162A1 (xx)
AT (1) AT380020B (xx)
AU (1) AU520715B2 (xx)
BE (1) BE863808A (xx)
CA (1) CA1093554A (xx)
CH (1) CH635344A5 (xx)
CZ (1) CZ279815B6 (xx)
DD (1) DD134099A5 (xx)
DE (1) DE2807393A1 (xx)
DK (1) DK144944C (xx)
EG (1) EG13399A (xx)
ES (1) ES467153A1 (xx)
FI (1) FI67082C (xx)
FR (2) FR2381047A1 (xx)
GB (1) GB1572137A (xx)
GR (1) GR71704B (xx)
HU (1) HU179422B (xx)
IE (1) IE46402B1 (xx)
IL (1) IL54052A (xx)
IN (1) IN149574B (xx)
LU (1) LU79067A1 (xx)
MX (1) MX5288E (xx)
NL (1) NL190285C (xx)
NO (1) NO147793C (xx)
NZ (1) NZ186465A (xx)
PL (1) PL118654B1 (xx)
PT (1) PT67656B (xx)
SE (1) SE437028B (xx)
SU (1) SU747427A3 (xx)
YU (1) YU40505B (xx)
ZA (1) ZA78837B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5838285A (ja) * 1981-08-25 1983-03-05 Kanegafuchi Chem Ind Co Ltd ５−メチル−（６ｒｓ）−５，６，７，８−テトラヒドロ−ｌ−葉酸のマグネシウム塩またはその遊離酸の製法
GB8621268D0 (en) * 1986-09-03 1986-10-08 Univ Strathclyde Separation of substances
IT1229517B (it) * 1989-01-31 1991-09-03 Bioresearch Spa Impiego di acido 5-metiltetraidrofolico, di acido 5 formiltetraidrofolico, e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato adatte ad essere impiegate nella terapia dei disordini depressivi e composizioni farmaceutiche relative.
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
NL8901432A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan.
CH680731A5 (xx) * 1990-04-12 1992-10-30 Sapec Fine Chemicals
US5217974A (en) * 1991-03-29 1993-06-08 Eli Lilly And Company Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity
CH683261A5 (it) * 1991-10-10 1994-02-15 Applied Pharma Res Procedimento per la preparazione dell'acido metiltetraidrofolico nella forma (6(R,S)(-))N-5 e separazione del diastereoisomero attivo (6(S)(-))N-5) sotto forma di sali.
CH682665A5 (de) * 1991-10-29 1993-10-29 Sapec Fine Chemicals Verfahren zur Reinigung von rohen Erdalkalimetallsalzen von N(5)-Methyl-5,6,7,8-tetrahydrofolsäure.
US6162914A (en) * 1998-04-24 2000-12-19 Cerbios-Pharma S.A. Process for the reduction of pterins
CH693905A5 (de) * 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
CH698729B1 (de) * 2007-05-30 2009-10-15 Cerbios Pharma Sa Stabile, kristalline (6S)-N(5)-Methyl-5, 6,7,8-tetrahydrofolsäure.
CN103214487A (zh) * 2013-04-12 2013-07-24 张家港威胜生物医药有限公司 一种重要医药化工原料(6s)-5-甲基四氢叶酸盐的合成
WO2015193778A1 (en) 2014-06-16 2015-12-23 Mylan Laboratories Ltd. Crystalline form of levomefolate calcium
EP3844145A4 (en) 2018-08-28 2022-05-11 PMC Organometallix, Inc. LOW FREE 2-MERCAPTOETHANOLE ESTER CONTENT AND ITS USES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL80276C (xx) *
GB1293541A (en) * 1969-03-18 1972-10-18 John Alexander Blair Folic acid derivatives
US3856959A (en) * 1972-07-24 1974-12-24 Department Of Health Education Inhibition of leukemia utilizing 5-methyltetrahydrohomofolate
US4148999A (en) * 1977-08-22 1979-04-10 The Government Of The United States Of America Preparation and purification of citrovorum factor
CH649550A5 (en) * 1984-02-09 1985-05-31 Eprova Ag Process for the preparation of alkaline earth metal salts of 5-methyltetrahydrofolic acid

Also Published As

Publication number Publication date
PL204747A1 (pl) 1979-03-12
FI67082C (fi) 1985-01-10
SE7801973L (sv) 1978-08-23
FR2381047A1 (fr) 1978-09-15
LU79067A1 (fr) 1978-06-27
MX5288E (es) 1983-06-06
IN149574B (xx) 1982-01-30
AR215162A1 (es) 1979-09-14
PL118654B1 (en) 1981-10-31
BE863808A (fr) 1978-05-29
NL190285C (nl) 1994-01-03
SE437028B (sv) 1985-02-04
NO147793B (no) 1983-03-07
YU40505B (en) 1986-02-28
DK76578A (da) 1978-08-23
FI67082B (fi) 1984-09-28
NO780594L (no) 1978-08-23
CZ112978A3 (en) 1995-02-15
NO147793C (no) 1983-06-15
FR2385397A1 (fr) 1978-10-27
NL190285B (nl) 1993-08-02
AU3343078A (en) 1979-08-30
FR2385397B1 (xx) 1981-07-17
PT67656B (en) 1979-07-19
FI780565A (fi) 1978-08-23
DD134099A5 (de) 1979-02-07
IL54052A (en) 1981-07-31
DE2807393C2 (xx) 1990-06-13
YU37978A (en) 1983-01-21
ZA78837B (en) 1979-09-26
SU747427A3 (ru) 1980-07-23
FR2381047B1 (xx) 1981-07-24
CH635344A5 (en) 1983-03-31
IL54052A0 (en) 1978-04-30
CA1093554A (en) 1981-01-13
DE2807393A1 (de) 1978-09-07
EG13399A (en) 1981-12-31
AU520715B2 (en) 1982-02-25
PT67656A (en) 1978-03-01
HU179422B (en) 1982-10-28
JPS5831353B2 (ja) 1983-07-05
JPS53124297A (en) 1978-10-30
GB1572137A (en) 1980-07-23
ATA90378A (de) 1985-08-15
NZ186465A (en) 1980-10-08
NL7801775A (nl) 1978-08-24
ES467153A1 (es) 1978-11-16
GR71704B (xx) 1983-06-21
IE780285L (en) 1978-08-22
AT380020B (de) 1986-03-25
CZ279815B6 (cs) 1995-07-12
DK144944B (da) 1982-07-12
IE46402B1 (en) 1983-06-01

Similar Documents

Publication Publication Date Title
DK331881A (da) Fremgangsmaade til fremstilling af trisubstituerede imidazolderivater eller salte deraf
DK144010C (da) Analogifremgangsmaade til fremstilling af 2-piperazinyl-6,7-dimethoxyquinazoliner eller syreadditionssalte deraf
DK405881A (da) Fremgangsmaade til fremstilling af 7beta-aminothiadiazolylacetylamino3-ammoniomethyl-3-cephem-4-carboxylsyreforbindelser eller salte deraf
DK294780A (da) Fremgangsmaade til fremstilling af trans-3-(4-oxo4h-quinazolin-3-yl)-2-propensyrederivater eller salte deraf
DK157079C (da) Fremgangsmaade til fremstilling af 7beta-amino-3-cephem-3-ol-4-carboxylsyreforbindelser eller salte deraf
DK144944C (da) Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf
DK536480A (da) Fremgangsmaade til fremtlling af isoquinolineddikesyre-forbindelser eller salte deraf
DK413783A (da) Fremgangsmaade til fremstilling af 20-amino-macrolidderivater eller syreadditionssalte deraf
DK453181A (da) Fremgangsmaade til fremstilling af 2-quanidino-4-heteroaryl-thiazolforbindelser eller syreadditionssalte deraf
DK334581A (da) Fremgangsmaade til frmstilling af 9-amino-1-hydroxyotahydro-6h-benzo (c) quinolin-derivater eller syreadditionssalte deraf
DK158977C (da) Fremgangsmaade til fremstilling af substituerede guanidiner eller salte deraf
DK142080C (da) Fremgangsmaade til fremstilling af 1-azolyl-3,3-dimethyl-1-phenoxy-butan-2-oner
DK495780A (da) Fremgangsmaade til fremstilling af 2-keto-l-gulonsyre eller salte deraf
DK365980A (da) Fremgangsmaade til fremstilling af 7-betaaminothiadiazolylacetylamino-3-cephem-4-carboxylsyreforbindelser eller salte deraf
DK144569C (da) Fremgangsmaade til fremstilling af et antibiotisk anthracyclin-glycosid-kompleks kaldet baumycin-kompleks eller komponenter,syreadditionssalte eller deoxyribonukleinsyrekomplekser deraf
DK152672C (da) Fremgangsmaade til fremstilling af 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-t-butylaminoethyl)pyridin eller syreadditionssalte heraf
DK155081A (da) Fremgangsmaade til fremstilling af 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaensyre eller salte heraf
DK158837C (da) Fremgangsmaade til fremstilling af p-hydroxyphenylglycin.
DK143340C (da) Fremgangsmaade til fremstilling af 2-(4-furoylpiperazin-1-yl)-4-amino-6,7-dimethoxyquinazoliner
DK152501C (da) Fremgangsmaade til fremstilling af pyrrolooe1,2-aaapyrimidiner eller salte deraf
DK153843C (da) Analogifremgangsmaade til fremstilling af 5-substituerede 10,11-dihydro-5h-dibenzooea,daacyclohepten-5,10-iminer eller salte deraf
DK366081A (da) Fremgangsmaade til fremstilling af diaryl-imidazol-forbindelser eller salte deraf
DK154085C (da) Fremgangsmaade til fremstilling af 1,1-dioxopenicillansyrederivater
DK145225C (da) Analogifremgangsmaade til fremstilling af 1-(3-trimethoxyphenoxy-2-hydroxy-propyl)-4-phenyl-piperazinderivater eller syreadditionssalte deraf
DK152040C (da) Analogifremgangsmaade til fremstilling af bibenzylderivater eller syreadditionssalte deraf

Legal Events

Date Code Title Description
PUP Patent expired